Acute Porphyria Drug Database

Monograph

J05AB06 - Ganciclovir
Not porphyrinogenic
NP

Rationale
Synthetic nucleoside . Mainly unmetabolized. Two references consider it safe.
Chemical description
Antiviral (CMV) synthetic nucleoside. Excreted (90%) in unchanged form. South African list: use. French list: use. Thunell: Given to one female AIP patient, 52 years, without ill effects

Similar drugs
Explore alternative drugs in similar therapeutic classes J05A / J05AB or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Cymevene · Cymevene 500 mg, poeder voor concentraat voor oplossing voor infusie · Ganciclovir · Ganciclovir Sandoz 500 mg, poeder voor concentraat voor oplossing voor infusie
Belgium
Cymevene · Cymevene 500 mg sol. perf. (pdr.) i.v. flac.
United Kingdom
Cymevene · Cymevene 250mg capsules · Cymevene 500mg capsules · Cymevene 500mg powder for concentrate for solution for infusion vials · Ganciclovir · Ganciclovir 500mg powder for concentrate for solution for infusion vials
Denmark
Cymevene · Ganciclovir · Ganciclovir "Oresund Pharma"
Norway
Cymevene · Ganciclovir Oresund Pharma
Poland
Cymevene · Ganciclovir Accord
Luxembourg
Cymeven · Cymeven i.v.
Finland
Cymevene · Ganciclovir Oresund Pharma
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙